RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP) Platform
–News Direct– Collaboration will explore trans-arterial delivery of Imugenes CF33 oncolytic virus utilizing RenovoRxs TAMP therapy platform. TAMP enables localized, targeted delivery of CF33...
